ASCENTAGE PHARMA GROUP INTERNATIONAL

ASCENTAGE PHARMA GROUP INTERNATIONALverified

AAPG

Price:

$30.7

Market Cap:

$20.18B

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL prote...[Read more]

Industry

Biotechnology

IPO Date

2025-01-24

Stock Exchange

NASDAQ

Ticker

AAPG

The PE Ratio as of December 2025 (TTM) for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) is -14.98

According to ASCENTAGE PHARMA GROUP INTERNATIONAL’s latest financial reports and current stock price. The company's current PE Ratio is -14.98. This represents a change of 235.42% compared to the average of -4.47 of the last 4 quarters.

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Historical PE Ratio (quarterly & annually)

How has AAPG PE Ratio performed in the past?

The mean historical PE Ratio of ASCENTAGE PHARMA GROUP INTERNATIONAL over the last ten years is -28.94. The current -14.98 PE Ratio has changed 5.08% with respect to the historical average. Over the past ten years (40 quarters), AAPG's PE Ratio was at its highest in in the June 2024 quarter at 57.42. The PE Ratio was at its lowest in in the June 2017 quarter at -409.12.

Quarterly (TTM)
Annual

Average

-28.94

Median

-9.40

Minimum

-94.51

Maximum

-4.32

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ASCENTAGE PHARMA GROUP INTERNATIONAL PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 904.91%

Maximum Annual PE Ratio = -4.32

Minimum Annual Increase = -75.88%

Minimum Annual PE Ratio = -94.51

Quarterly (TTM)
Annual
YearPE RatioChange
2024-94.51904.91%
2023-9.405.09%
2022-8.95-0.36%
2021-8.98-0.58%
2020-9.03109.09%
2019-4.32-75.88%
2018-17.91-63.73%
2017-49.39-14.73%

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Average PE Ratio

How has AAPG PE Ratio performed in the past?

The current PE Ratio of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-37.62

5-year avg

-26.18

10-year avg

-28.94

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) PE Ratio vs. Peers

How is AAPG’s PE Ratio compared to its peers?

ASCENTAGE PHARMA GROUP INTERNATIONAL’s PE Ratio is greater than Centessa Pharmaceuticals plc (-17.15), greater than Apogee Therapeutics, Inc. (-17.49), greater than Celcuity Inc. (-29.14), less than Xenon Pharmaceuticals Inc. (-12.66), greater than CG Oncology, Inc. Common stock (-31.87), less than Zai Lab Limited (-10.30), less than Legend Biotech Corporation (-7.86), less than Ultragenyx Pharmaceutical Inc. (-6.29), greater than Disc Medicine, Inc. (-18.22), greater than Soleno Therapeutics, Inc. (-35.81),

Build a custom stock screener for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ASCENTAGE PHARMA GROUP INTERNATIONAL using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ASCENTAGE PHARMA GROUP INTERNATIONAL or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ASCENTAGE PHARMA GROUP INTERNATIONAL's PE Ratio?

How is the PE Ratio calculated for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?

What is the highest PE Ratio for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?

What is the 3-year average PE Ratio for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?

What is the 5-year average PE Ratio for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?

How does the current PE Ratio for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) compare to its historical average?